Publications by authors named "Ching-Tso Chen"

Claim this Profile
R
Response to comment on "Comparative analysis of preoperative chemotherapy versus postoperative chemotherapy in advanced soft tissue sarcoma".
Ching-Tso Chen, Tom Wei-Wu Chen

J Formos Med Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of patients who received atezolizumab plus bevacizumab treatment for advanced hepatocellular carcinoma.
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, San-Chi Chen, Chih-Hung Hsu

J Formos Med Assoc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Ching-Tso Chen, Chien-Huai Chuang, Chih-Hung Hsu, Yu-Yun Shao

J Hepatocell Carcinoma· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of anti-epidermal growth factor receptor antibodies plus trifluridine-tipiracil as rechallenge strategy improves treatment outcomes in patients with RAS/BRAF wild-type refractory metastatic colorectal cancer.
Ching-Tso Chen, Yi-Hsin Liang, Been-Ren Lin, Kuo-Hsing Chen, Kun-Huei Yeh

Am J Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial.
Yu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, Tung-Hung Su, Ming-Chih Ho, Ann-Lii Cheng

Br J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carry-over effect of immunotherapy in patients with advanced hepatocellular carcinoma.
Chien-Huai Chuang, Ching-Tso Chen, Chih-Hung Hsu, Yu-Yun Shao

Cancer Immunol Immunother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.
Choong-Kun Lee, Changhoon Yoo, Jung Yong Hong, Se Jun Park, Jin Won Kim, San-Chi Chen, Ching-Tso Chen

Liver Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential multimodal treatments with chemotherapy and surgery for advanced soft tissue sarcoma may be associated with better survival than chemotherapy.
Ching-Tso Chen, Hsing-Wu Chen, Wei-Hsin Lin, Pei-Ming Huang, Mong-Wei Lin, Ho-Min Chen, Tom Wei-Wu Chen

J Formos Med Assoc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment.
Ching-Tso Chen, Yin-Hsun Feng, Chia-Jui Yen, San-Chi Chen, Yun-Tzu Lin, Ann-Lii Cheng

Hepatol Int· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding Sorafenib Treatment for Hepatocellular Carcinoma Beyond Barcelona Clinic Liver Cancer Stage C Patients: A National Study.
Ching-Tso Chen, Chih-Hung Hsu, Ann-Lii Cheng, Yu-Yun Shao

Anticancer Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.
Ching-Tso Chen, Tsung-Hao Liu, Yu-Yun Shao, Kao-Lang Liu, Po-Chin Liang

Int J Mol Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis